Tim Gleeson
Overview
An experienced entrepreneur and investor specializing in healthcare and medical device sectors. Tim Gleeson has over two decades of experience in executive leadership roles within the medical device sector. He founded and led Novasyte Health from its inception to its acquisition by IQVIA, and has held executive positions at Medtronic. He has also invested in healthcare ventures like Genmark Dx, Mesa Biotech, and Truvian. In February 2024, he was appointed CEO and Board Member of BRIJ Medical, a company focused on post-surgical and trauma incision care. Under his leadership, BRIJ Medical has achieved significant milestones, including being selected for the MedTech Innovator 2025 Accelerator Cohort and being named a finalist in the MedTech Innovator’s 2025 Mid-Stage Grand Prize Competition.
Investment Focus
- Innovative healthcare solutions
- Strong management teams
- Scalable business models
Portfolio Companies
Get the full list of 54,000+ investors
Tim Gleeson and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Tim Gleeson
What sectors does Tim Gleeson invest in?
Tim Gleeson invests in Healthcare and Medical Devices, and is based in Georgia, United States. Tim Gleeson is listed as a angel investor in the ConnectSafely investor database.
What stage does Tim Gleeson invest at?
Tim Gleeson backs companies at Seed and Early Stage.
Which regions does Tim Gleeson invest in?
Tim Gleeson invests across United States.
What companies has Tim Gleeson invested in?
Tim Gleeson's portfolio includes Mesa Biotech, BRIJ Medical, Novasyte Health, Genmark Dx and Truvian.
Last updated · Source: ConnectSafely investor database